RNAi Message Board - Msg: 19935497

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : RNAi

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: bob zagorin who wrote (195)	3/19/2004 2:46:22 PM
From: Gulo	Read Replies (1) of 671

The insider sales at ISIS have me spooked. Insiders unwillingness to hold on to shares suggests that they feel the run-up over the last year is not sustainable. On the other hand, ISIS has a couple year's of cash left, their revenue covers 1/3 of their cash burn and the market cap might be justified by their pipeline. I like their drug pipeline, at least what little I know of it so far, but the antibioterror stuff isn't as interesting to me. Maybe that's because I know so little about it "Tiger". It might get to market faster than a drug would, and may drive a spike in share price if a bioterrorist attack occurs. -g

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next